References

  1. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. 35th ed. http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/UCM071436.pdf. Accessed February 19, 2015.
  2. AGGRENOX [package insert]. Ridgefield, CT: Boehringer Ingelheim Pharmaceuticals, Inc; 2012.
  3. Sacco RL, Diener HC, Yusuf S, et al; PRoFESS Study Group. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med. 2008;359(12):1238-1251.
  4. Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A; European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci. 1996;143(1-2):1-13.
;